Find and Pitch Jounalists, Get Your Story Covered

Tags: infliximab infection ulcerative colitis colitis infusion

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 4 days ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 8 days ago Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer - about 1 month ago A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 7 months ago New First-Line Option for Pancreatic Cancer Approved - 7 months ago Axatilimab Shows Efficacy in Recurrent/Refractory GVHD - 9 months ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - 11 months ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - 11 months ago
2	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Lebrikizumab Wins FDA Approval for Eczema - 6 days ago FDA OKs Amivantamab as First-Line Lung Cancer Treatment - 7 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - 9 months ago Frontline Venetoclax-Ibrutinib for CLL Boosts Survival in Fit Patients - 9 months ago
3	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug - 6 days ago STAT+: FDA approves Lilly ulcerative colitis treatment with a new approach to tamping down inflammation - 11 months ago
4	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Non-Medical Switch to Infliximab Biosimilar Demonstrates Similar Outcomes for IBD - 7 days ago FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 7 days ago FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 3 months ago FDA Accepts sBLA for Bimekizumab-bkzx in Hidradenitis Suppurativa Treatment - 6 months ago FDA Approves Tocilizumab-aazg as Biosimilar to Actemra for Multiple Indications - 7 months ago Results Show Dupilumab Reduces Airway Inflammation In Asthma - 7 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 7 months ago FDA Approves Adalimumab-ryvk as Interchangeable Biosimilar for Humira - 7 months ago Biosimilar Adalimumab, Etanercept Have Equivalent Effectiveness to Reference Drugs Over 48 Months - 7 months ago Celltrion Seeks Approval From FDA for CT-P47 as Biosimilar of Tocilizumab - 8 months ago FDA Approves Targeted Release Budesonide for Treatment of Primary Immunoglobulin A Nephropathy - 9 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 10 months ago FDA Grants Breakthrough Therapy Designation to Epcoritamab for Follicular Lymphoma - 10 months ago FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira - 10 months ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - 11 months ago Subcutaneous Lecanemab Demonstrates Greater Amyloid Plaque Removal Than Intravenous Lecanemab - 11 months ago
5	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 15 days ago Medicare Lags, Medicaid Leads for Biosimilar Uptake - about 2 months ago Study Confirms: No Great Options for Treating VEXAS - 4 months ago Axial SpA: Gender Gap Confirmed in TNF Inhibitor Response - 9 months ago Novel IL-17A Blocker Continues to Impress in PsA - 10 months ago Novel Drug OK'd for Ulcerative Colitis - 11 months ago Bimekizumab Data in axSpA Look Good Through 1 Year - 12 months ago
6	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Axatilimab-csfr for cGVHD - about 1 month ago
7	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	New Study Assesses Ifinatamab Deruxtecan for Treatment of Small Cell Lung Cancer - about 1 month ago J&J Submits sBLA To FDA for Guselkumab in Ulcerative Colitis - 6 months ago Treatment With Anifrolumab-fnia Shows Promising Rates of Remission for Lupus - 11 months ago
8	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Amgen’s trial brings new hope for IgG4-RD patients - 4 months ago
9	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Dupilumab Reduces Airway Inflammation, Mucus Plugs in Asthma Patients - 6 months ago Pirtobrutinib Shows Potential in Heavily Pretreated Follicular Lymphoma - 8 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - 9 months ago Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years - 9 months ago Positive Results for Odronextamab in Relapsed/Refractory DLBCL - 9 months ago New Data on Bimekizumab in Psoriatic Arthritis - 10 months ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - 10 months ago A Novel Mechanism of Action in Treating Relapsing MS - 10 months ago New Data on CD40 Ligand Inhibitor for Relapsing MS - 10 months ago
10	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	Risankizumab Beats Ustekinumab for Previously Treated Crohn's - 7 months ago

Journalists covering infliximab